AxoGen (AXGN) Tops Q2 EPS by 2c

AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $14.38 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Nike updates Q4 fiscal 2026 outlook with tariff refund benefit
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal